DataMeds AI, Inc
MEDS Healthcare Pharmaceutical Retailers
DataMeds AI, Inc’s revenue for fiscal 2025 (year ended December 2025) was $23.3 million, up 28.7% from fiscal 2024. In the quarter to June 2026, revenue fell 77.2%, EPS fell 29.6%, free cash flow fell 41.9% and total debt fell 15.4%, each against the same quarter a year earlier.
Follow MEDS
DataMeds AI, Inc (MEDS) Altman Z-score
DataMeds AI, Inc's Altman Z-score for fiscal 2025 is −15.16, in the distress zone (below 1.81).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | −15.16 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (0.89) | — | −1.06 | |
| Retained earnings / total assets | (3.65) | — | −5.10 | |
| EBIT / total assets | (3.08) | — | −10.16 | |
| Market value of equity / total liabilities | 0.66 | — | 0.40 | |
| Sales / total assets | 0.77 | — | 0.77 | |
| Altman Z-score | Distress zone | −15.16 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −38.68 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| SCNX Scienture Holdings, Inc. compare | 5.4× |
| HITI High Tide Inc. compare | 1.5× |
| RDGT Ridgetech Inc. compare | 1.2× |
| PETS PetMed Express, Inc. compare | 0.4× |
| BIMI BIMI Holdings Inc. compare | −3.8× |
| MDVLQ MedAvail Holdings, Inc. compare | −11.8× |
| MEDS DataMeds AI, Inc | −15.2× |
| POM Pomdoctor Limited - Sponsored ADR compare | −33.3× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets